Hereditary nonpolyposis colorectal cancer surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(23 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hereditary nonpolyposis colorectal cancer}}
{{Hereditary nonpolyposis colorectal cancer}}
{{CMG}}{{AE}}{{MV}}
{{CMG}}{{AE}}{{MV}}{{Akram}}


==Overview==
==Overview==
Surgery is the mainstay of treatment for hereditary nonpolyposis colorectal cancer.<ref>Treatment of hereditary nonpolyposis colorectal cancer.Wikipedia.https://en.wikipedia.org/wiki/Hereditary_nonpolyposis_colorectal_cancer#Treatment Accessed on December 2, 2015</ref>
[[Surgery]] is the mainstay of treatment for hereditary nonpolyposis colorectal cancer. [[Surgery|Surgical]] [[resection]] is recommended for [[Patient|patients]] with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous [[colorectal cancer]]. [[colectomy|Subtotal colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] and [[Surgery|postsurgical]] [[Endoscopy|endoscopic]] [[rectal]] surveillance are advised when [[colorectal cancer]] develops in the setting of hereditary nonpolyposis colorectal cancer.


==Surgery==
==Surgery==


Surgical resection is recommended among patients with HPNCC because of the high rate of metachronous colorectal cancer. Subtotal colectomy with ileorectal anastomosis and postsurgical endoscopic rectal surveillance are advised when colorectal cancer develops in the setting of HNPCC.
*[[Surgery|Surgical]] [[resection]] is recommended for [[Patient|patients]] with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous [[colorectal cancer]].  
*Common [[Surgery|surgical]] techniques for the [[resection]] of hereditary nonpolyposis colorectal cancer include:
:*[[Colectomy|Subtotal colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] and [[Surgery|postsurgical]] [[Endoscopy|endoscopic]] [[rectal]] surveillance ([[Surgery|surgical]] treatment of choice in the setting of hereditary nonpolyposis colorectal cancer)
:*[[Proctocolectomy]] with [[ileostomy]]
:*[[Colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] and/or [[proctocolectomy]] with [[Ileo-anal pouch|ileo-anal "pouch]]"<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>
:*[[Proctocolectomy]] with [[ileostomy]]
:*[[Colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]]
:*[[Proctocolectomy]] with [[Ileo-anal pouch|ileo-anal "pouch"]] S, J, W or H<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>
:*[[Hysterectomy]] and adnexectomy (in [[female]] hereditary nonpolyposis colorectal cancer [[Patient|patients]]) due to increased risk of primary [[Endometrial cancer|endometrial]] and [[Ovarian cancer|ovarian cancers]]
:*[[Endoscopy|Endoscopic]] [[polypectomy]] (recommended in the case of [[Polyp|polyps]] which are [[benign]] and non-recurrent)
*[[Surgery|Surgical]] procedures for hereditary nonpolyposis colorectal cancer are characterized by increasing frequency of [[Complication (medicine)|complications]].
*Complex [[Surgery|surgical]] procedures are related with higher number of [[Complication (medicine)|complications]], but lower recurrence rates.
*[[Prophylaxis|Prophylactic]] [[colectomy]] should be considered in [[Patient|patients]] with [[Adenoma|adenomas]] that are multiple and/or recurrent and/or of a significant degree of [[dysplasia]] and/or [[Villous adenoma|villous]].
*The high proportion of [[Synchronicity|synchronous]] [[Tumor|tumors]] (more than 15% of [[Patient|patients]] at the time of [[diagnosis]]) or metachronous [[Tumor|tumors]] (about 45% during 10 years following [[surgery]] of the primary [[tumor]]) [[Indication (medicine)|indicates]] [[Prevention (medical)|preventive]] [[surgery]] as for [[surgery]] in [[Patient|patients]] of hereditary nonpolyposis colorectal cancer.<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>


The following types of surgical treatment are recommended: Proctocolectomy with ileostomy, colectomy with ileo-rectal anastomosis and/or proctocolectomy with ileo-anal "pouch".<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (HNPCC). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref> The first of the proposed procedures is the most radical but later the risk of recurrence is very low. However, such treatment is highly traumatising and frequently leads to urinary tract abnormalities and sexual dysfunction. On the other hand, colectomy with ileorectal anastomosis does not lead to such complications but should be followed by frequent examinations due to the risk of cancer in the unresected fragment of bowel. Proctocoloctomy with ileo-anal "pouch" S, J, W or H is a method with a relatively short history so it is difficult to conclude about it definitely.<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (HNPCC). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>
Common [[Surgery|surgical]] [[Complication (medicine)|complications]] of hereditary nonpolyposis colorectal cancer may include:  
 
*[[Urinary system|Urinary tract]] abnormalities
It is recommended that female HNPCC patients undergoing surgery due to colorectal cancer and at perimenopausal age or older should also consider extending their surgery to receive a hysterectomy and adnexectomy due to increased risk of primary endometrial and ovarian cancers. All of the above procedures are characterized by increasing frequency of complications. However, they are recommended in the treatment of HNPCC because the really important problem for this patient is the high risk of second primary colorectal cancer.
*[[Sexual dysfunction]]
 
Endoscopic polypectomy is recommended in the case of polyps which are benign and non-recurrent. However, in patients with adenomas that are multiple and/or recurrent and/or of a significant degree of dysplasia and/or villous, prophylactic colectomy should be considered. The high proportion of synchronous tumors (more than 15% of patients at the time of diagnosis) or metachronous tumors (about 45% during 10 years following surgery of the primary tumor) suggests that for preventive surgery as for surgery in patients from HNPCC families with histopathologically diagnosed.<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (HNPCC). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>


==Prophylactic Surgery==
==Prophylactic Surgery==


The feasibility of prophylactic surgery of the colon, uterus and ovaries depends on a individual basis for HNPCC patients.<ref name="pmid21037810">{{cite journal |vauthors=Gryfe R |title=Inherited colorectal cancer syndromes |journal=Clin Colon Rectal Surg |volume=22 |issue=4 |pages=198–208 |year=2009 |pmid=21037810 |pmc=2796102 |doi=10.1055/s-0029-1242459 |url=}}</ref><ref name="pmid16421367">{{cite journal |vauthors=Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH |title=Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome |journal=N. Engl. J. Med. |volume=354 |issue=3 |pages=261–9 |year=2006 |pmid=16421367 |doi=10.1056/NEJMoa052627 |url=}}</ref> However, in some cases screen-detected family members and symptomatic individuals (mostly in their 30s) are eligible for prophylactic colorectal surgery.
*The feasibility of [[Prophylaxis|prophylactic]] [[surgery]] of the [[Colon (anatomy)|colon]], [[uterus]], and [[Ovary|ovaries]] varies from [[patient]] to [[patient]].<ref name="pmid21037810">{{cite journal |vauthors=Gryfe R |title=Inherited colorectal cancer syndromes |journal=Clin Colon Rectal Surg |volume=22 |issue=4 |pages=198–208 |year=2009 |pmid=21037810 |pmc=2796102 |doi=10.1055/s-0029-1242459 |url=}}</ref>  
 
*In some cases screen-detected [[family]] members and [[symptomatic]] individuals (young [[Adult|adults]]) are eligible for [[Prophylaxis|prophylactic]] [[colorectal surgery]].  
Most experts believe that prophylactic surgery should not be recommended to patients without any pathological changes of the colon even if such persons are carriers of a mutation.
 
==Gallery==
 
<gallery>
Image:Lynchsyndrome grosspathology.jpg| Right image: Total colectomy for multiple metachronous colon cancer<SMALL><SMALL>''[Creative Commons BY-SA-NC]''<ref name="creativecommons1">Kochi M, Shimomura M, Hinoi T, et al. Total colectomy for multiple metachronous colon cancers in a patient with Lynch syndrome. Surg Case Rep. 2015;1(1):78.</ref>
</gallery>
 


*[[Prophylaxis|Prophylactic]] [[surgery]] should not be recommended for [[Patient|patients]] without any [[Pathology|pathological]] changes in the [[Colon (anatomy)|colon]] even if such individuals are [[Carrier|carriers]] of a [[mutation]].<ref name="pmid16421367">{{cite journal |vauthors=Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH |title=Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome |journal=N. Engl. J. Med. |volume=354 |issue=3 |pages=261–9 |year=2006 |pmid=16421367 |doi=10.1056/NEJMoa052627 |url=}}</ref>


==References==
==References==
Line 35: Line 39:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Needs content]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Surgery]]

Latest revision as of 13:56, 30 April 2019

Hereditary Nonpolyposis Colorectal Cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hereditary Nonpolyposis Colorectal Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hereditary nonpolyposis colorectal cancer surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hereditary nonpolyposis colorectal cancer surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hereditary nonpolyposis colorectal cancer surgery

CDC on Hereditary nonpolyposis colorectal cancer surgery

Hereditary nonpolyposis colorectal cancer surgery in the news

Blogs on Hereditary nonpolyposis colorectal cancer surgery

Directions to Hospitals Treating Hereditary nonpolyposis colorectal cancer

Risk calculators and risk factors for Hereditary nonpolyposis colorectal cancer surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]Ali Akram, M.B.B.S.[3]

Overview

Surgery is the mainstay of treatment for hereditary nonpolyposis colorectal cancer. Surgical resection is recommended for patients with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous colorectal cancer. Subtotal colectomy with ileo-rectal anastomosis and postsurgical endoscopic rectal surveillance are advised when colorectal cancer develops in the setting of hereditary nonpolyposis colorectal cancer.

Surgery

Common surgical complications of hereditary nonpolyposis colorectal cancer may include:

Prophylactic Surgery

References

  1. 1.0 1.1 1.2 Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.
  2. Gryfe R (2009). "Inherited colorectal cancer syndromes". Clin Colon Rectal Surg. 22 (4): 198–208. doi:10.1055/s-0029-1242459. PMC 2796102. PMID 21037810.
  3. Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH (2006). "Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome". N. Engl. J. Med. 354 (3): 261–9. doi:10.1056/NEJMoa052627. PMID 16421367.


Template:WikiDoc Sources